Cliff Asness's KNSA Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 378,697 shares of Kiniksa Pharmaceuticals International, plc (KNSA) worth $18.23 M, representing 0.01% of the portfolio. First purchased in 2020-Q2, this medium-term investment has been held for 18 quarters.
Based on 13F filings, Cliff Asness has maintained a strategic position in KNSA, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2025, adding 294,319 shares. Largest reduction occurred in Q3 2023, reducing 187,444 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Kiniksa Pharmaceuticals International plc (KNSA) Holding Value Over Time
Track share changes against reported price movement
Quarterly Kiniksa Pharmaceuticals International plc (KNSA) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +25,635 | Add 7.26% | 378,697 | $48.15 |
| Q4 2025 | +20,645 | Add 6.21% | 353,062 | $41.25 |
| Q3 2025 | -65,815 | Reduce 16.53% | 332,417 | $38.83 |
| Q2 2025 | -93,529 | Reduce 19.02% | 398,232 | $27.67 |
| Q1 2025 | +294,319 | Add 149.07% | 491,761 | $22.21 |
| Q4 2024 | +13,273 | Add 7.21% | 197,442 | $19.78 |
| Q3 2024 | +58,174 | Add 46.17% | 184,169 | $24.99 |
| Q2 2024 | -33,328 | Reduce 20.92% | 125,995 | $18.67 |
| Q1 2024 | -68,722 | Reduce 30.14% | 159,323 | $19.73 |
| Q4 2023 | -95,533 | Reduce 29.52% | 228,045 | $17.54 |
| Q3 2023 | -187,444 | Reduce 36.68% | 323,578 | $17.37 |
| Q2 2023 | +103,260 | Add 25.32% | 511,022 | $14.08 |
| Q1 2023 | +262,747 | Add 181.19% | 407,762 | $10.76 |
| Q4 2022 | +145,015 | New Buy | 145,015 | $14.98 |
| Q1 2021 | -15,390 | Sold Out | 0 | $0.00 |
| Q4 2020 | -2,868 | Reduce 15.71% | 15,390 | $17.67 |
| Q3 2020 | +7,017 | Add 62.42% | 18,258 | $15.34 |
| Q2 2020 | +11,241 | New Buy | 11,241 | $25.44 |
Cliff Asness's Kiniksa Pharmaceuticals International plc Investment FAQs
Cliff Asness first purchased Kiniksa Pharmaceuticals International, plc (KNSA) in Q2 2020, acquiring 11,241 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Kiniksa Pharmaceuticals International, plc (KNSA) for 18 quarters since Q2 2020.
Cliff Asness's largest addition to Kiniksa Pharmaceuticals International, plc (KNSA) was in Q1 2025, adding 491,761 shares worth $10.92 M.
According to the latest 13F filing for Q1 2026, Cliff Asness's firm, Aqr Capital Management LLC, owns 378,697 shares of Kiniksa Pharmaceuticals International, plc (KNSA), valued at approximately $18.23 M.
As of the Q1 2026 filing, Kiniksa Pharmaceuticals International, plc (KNSA) represents approximately 0.01% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Kiniksa Pharmaceuticals International, plc (KNSA) was 511,022 shares, as reported at the end of Q2 2023.